Alaunos Therapeutics | ZIOP - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Alaunos Therapeutics

Alaunos Therapeutics Inc reported $3.17M in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
Alaunos Therapeutics Inc ZIOP:US USD 3.17M 243K
Amgen AMGN:US USD 1.26B 210M
AstraZeneca AZN:LN USD 3.2B 331M
Baxter International BAX:US USD 774M 212M
Biogen BIIB:US USD 605M 27.8M
Bristol-Myers Squibb BMY:US USD 1.76B 504M
Corcept Therapeutics CORT:US USD 48.56M 6.24M
Curis CRIS:US USD 4.76M 430K
Gilead Sciences GILD:US USD 1.32B 702M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
Immunogen IMGN:US USD 40.02M 2.05M
Incyte Corp INCY:US USD 315.61M 42.79M
Intercept Pharmaceuticals ICPT:US USD 57.66M 2.37M
Intrexon XON:US USD 11.64M 129K
Ionis Pharmaceuticals IONS:US USD 45.52M 2.43M
J&J JNJ:US USD 6.14B 374M
Karyopharm Therapeutics KPTI:US USD 35.91M 1.26M
Merck & Co MRK:US USD 2.46B 209M
Novartis NOVN:VX USD 3.4B 298M
Pfizer PFE:US USD 3.49B 1.39B
PTC Therapeutics PTCT:US USD 86.91M 5.8M
Regeneron Pharmaceuticals REGN:US USD 601.1M 59.4M
Roche Holding ROG:VX CHF 6.48B 834M
Sangamo BioSciences SGMO:US USD 18.14M 1.69M
TG Therapeutics TGTX:US USD 28.07M 5.56M
Verastem VSTM:US USD 7.33M 1.22M